Fundamental Valuation Report AbbVie(ABBV:NYS) Healthcare:Drug Manufacturers-Major This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$79.24 (USD) 28/02/2019 Weighted Valuation$92.73 (USD) Overall RatingUndervalued by 17.0% Valuation Models Analyst Consensus: $92.73 (USD) (in …
AbbVie (ABBV:NYS) Fundamental Valuation Report Read more »
Read MoreFundamental Valuation Report Acorda Therapeutics(ACOR:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$14.74 (USD) 28/02/2019 Weighted Valuation$21.10 (USD) Overall RatingUndervalued by 43.2% Valuation Models Analyst Consensus: $23.67 (USD) (in …
Acorda Therapeutics (ACOR:NAS) Fundamental Valuation Report Read more »
Read MoreFundamental Valuation Report Aduro Biotech(ADRO:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$4.30 (USD) 28/02/2019 Weighted Valuation$6.65 (USD) Overall RatingUndervalued by 54.7% Valuation Models Analyst Consensus: $8.00 (USD) (in …
Aduro Biotech (ADRO:NAS) Fundamental Valuation Report Read more »
Read MoreFundamental Valuation Report Amarin Corp(AMRN:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$20.47 (USD) 28/02/2019 Weighted Valuation$37.42 (USD) Overall RatingUndervalued by 82.8% Valuation Models Analyst Consensus: $43.00 (USD) (in …
Amarin Corp (AMRN:NAS) Fundamental Valuation Report Read more »
Read MoreFundamental Valuation Report Alliance Data Systems(ADS:NYS) Financial Services:Credit Services This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$173.27 (USD) 27/02/2019 Weighted Valuation$187.85 (USD) Overall RatingUndervalued by 8.4% Valuation Models Analyst …
Alliance Data Systems (ADS:NYS) Fundamental Valuation Report Read more »
Read MoreFundamental Valuation Report Apellis Pharmaceuticals(APLS:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$14.24 (USD) 27/02/2019 Weighted Valuation$37.26 (USD) Overall RatingUndervalued by 161.7% Valuation Models Analyst Consensus: $53.00 (USD) (in …
Apellis Pharmaceuticals (APLS:NAS) Fundamental Valuation Report Read more »
Read MoreFundamental Valuation Report Alcoa(AA:NYS) Basic Materials:Aluminum This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$30.98 (USD) 27/02/2019 Weighted Valuation$38.84 (USD) Overall RatingUndervalued by 25.4% Valuation Models Analyst Consensus: $40.00 (USD) (in …
Alcoa (AA:NYS) Fundamental Valuation Report Read more »
Read MoreFundamental Valuation Report Blue Apron Holdings(APRN:NYS) Consumer Cyclical:Specialty Retail This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$1.29 (USD) 26/02/2019 Weighted Valuation$1.78 (USD) Overall RatingUndervalued by 38.0% Valuation Models Analyst …
Blue Apron Holdings (APRN:NYS) Fundamental Valuation Report Read more »
Read MoreFundamental Valuation Report Bristol-Myers Squibb(BMY:NYS) Healthcare:Drug Manufacturers-Major This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$50.16 (USD) 26/02/2019 Weighted Valuation$57.99 (USD) Overall RatingUndervalued by 15.6% Valuation Models Analyst Consensus: $58.00 (USD) …
Bristol-Myers Squibb (BMY:NYS) Fundamental Valuation Report Read more »
Read MoreFundamental Valuation Report Alimera Sciences(ALIM:NAS) Healthcare:Drug Manufacturers-Major This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$1.12 (USD) 26/02/2019 Weighted Valuation$2.33 (USD) Overall RatingUndervalued by 108.0% Valuation Models Analyst Consensus: $2.75 (USD) …
Alimera Sciences (ALIM:NAS) Fundamental Valuation Report Read more »
Read More